| | | |
Webcasts
|
Lessons Learned From HTS: The Short and Long Journey to Probe Discovery
16 August 2010
Hakim Djaballah, Director, Memorial Sloan Kettering Cancer Center, speaking at Probe Discovery 2009
|
|
|
|
Lead-discovery and Probe Development in Smaller Academic-based HTS Labs
08 July 2010
Andy Mesecar, Professor, University of Illinois, speaking at Probe Discovery 2009
|
|
|
|
Exploratory Pharmacogenetic Analysis of Efalizumab Responders
07 June 2010
Emmanuel Monnet, Head of Biomarker, Merck Serono, speaking at Molecular Diagnostics World Congress 2009
|
|
|
|
Clinically Actionable Proteomic Biomarkers in Rheumatoid Arthritis
06 May 2010
Bill Robinson, Assistant Professor, Stanford University, speaking at Microarray World Congress 2009
|
|
|
|
New Approaches to Biomarker Detection
19 April 2010
John Park, Founder, Nanosurface Biosciences, speaking at Microarray World Congress 2009
|
|
|
|
Challenges in the Development of Tissue Biomarkers
19 March 2010
Steven Hewitt, Chief, Tissue Array Research Program, National Cancer Institute, Maryland, speaking at Microarray World Congress 2009
|
|
|
|
Chemogenomics: Medicinal Chemistry Meets Pharmacology at a Genome Scale
19 February 2010
Jordi Mestres, Head Chemogenomics Lab, Universitat Pompeu Fabra, speaking at MedChem Europe 2009
|
|
|
|
Enabling Personalised Medicine From FFPE Tissue
27 January 2010
Austin Tanney, Scientific Liaison Manager, Almac, speaking at Molecular Diagnostics Europe 2009
|
|
|
|
Advancing Drug Discovery in an Academic Setting
05 November 2009
Julie Frearson, Professor Biotechnology/Drug Discovery/Biological Chemistry and Molecular Pharmacology, University of Dundee, speaking at Screening Europe 2009
|
|
|
|
De Novo Molecular Design: A Powerful Strategy for the Discovery of New Potential Antimalarials and Antibacterials
09 October 2009
Colin Fishwick, Reader/ Director Organic Chemistry/Leeds Structure-Based Drug Design Group, University of Leeds School of Chemistry, speaking at MedChem Europe 2009
|
|
|
| |
| |
|